COVID-19 Impact on Artificial Blood Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Artificial Blood, including the following market information:
Major competitors identified in this market include Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma, Alpha Therapeutic Corporation, HemoBioTech, etc.
Based on the Region:
- Global Artificial Blood Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Artificial Blood Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Artificial Blood Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Artificial Blood Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Dextro-Sang Corporation, BioPure Corporation, Sangart, Northfield Laboratories, Baxter International, Dentritech, FluorO2 Therapeutics, Nuvox Pharma, Alpha Therapeutic Corporation, HemoBioTech, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Human Blood
- Synthetic Blood
- Animal Blood
- Hemoglobin-Based Oxygen Carriers (HBOCs)
- Perflurocarbon Emulsions (PFCEs)
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Artificial Blood Industry
1.7 COVID-19 Impact: Artificial Blood Market Trends
2 GLOBAL ARTIFICIAL BLOOD QUARTERLY MARKET SIZE ANALYSIS
2.1 Artificial Blood Business Impact Assessment - COVID-19
2.1.1 Global Artificial Blood Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Artificial Blood Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Artificial Blood Quarterly Market Size, 2019 VS 2020
3.2 By Players, Artificial Blood Headquarters and Area Served
3.3 Date of Key Players Enter into Artificial Blood Market
3.4 Key Players Artificial Blood Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON ARTIFICIAL BLOOD SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Human Blood
1.4.2 Synthetic Blood
1.4.3 Animal Blood
4.2 By Type, Global Artificial Blood Market Size, 2019-2021
5 IMPACT OF COVID-19 ON ARTIFICIAL BLOOD SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hemoglobin-Based Oxygen Carriers (HBOCs)
5.5.2 Perflurocarbon Emulsions (PFCEs)
5.2 By Application, Global Artificial Blood Market Size, 2019-2021
5.2.1 By Application, Global Artificial Blood Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Dextro-Sang Corporation
7.1.1 Dextro-Sang Corporation Business Overview
7.1.2 Dextro-Sang Corporation Artificial Blood Quarterly Revenue, 2020
7.1.3 Dextro-Sang Corporation Artificial Blood Product Introduction
7.1.4 Dextro-Sang Corporation Response to COVID-19 and Related Developments
7.2 BioPure Corporation
7.2.1 BioPure Corporation Business Overview
7.2.2 BioPure Corporation Artificial Blood Quarterly Revenue, 2020
7.2.3 BioPure Corporation Artificial Blood Product Introduction
7.2.4 BioPure Corporation Response to COVID-19 and Related Developments
7.3 Sangart
7.3.1 Sangart Business Overview
7.3.2 Sangart Artificial Blood Quarterly Revenue, 2020
7.3.3 Sangart Artificial Blood Product Introduction
7.3.4 Sangart Response to COVID-19 and Related Developments
7.4 Northfield Laboratories
7.4.1 Northfield Laboratories Business Overview
7.4.2 Northfield Laboratories Artificial Blood Quarterly Revenue, 2020
7.4.3 Northfield Laboratories Artificial Blood Product Introduction
7.4.4 Northfield Laboratories Response to COVID-19 and Related Developments
7.5 Baxter International
7.5.1 Baxter International Business Overview
7.5.2 Baxter International Artificial Blood Quarterly Revenue, 2020
7.5.3 Baxter International Artificial Blood Product Introduction
7.5.4 Baxter International Response to COVID-19 and Related Developments
7.6 Dentritech
7.6.1 Dentritech Business Overview
7.6.2 Dentritech Artificial Blood Quarterly Revenue, 2020
7.6.3 Dentritech Artificial Blood Product Introduction
7.6.4 Dentritech Response to COVID-19 and Related Developments
7.7 FluorO2 Therapeutics
7.7.1 FluorO2 Therapeutics Business Overview
7.7.2 FluorO2 Therapeutics Artificial Blood Quarterly Revenue, 2020
7.7.3 FluorO2 Therapeutics Artificial Blood Product Introduction
7.7.4 FluorO2 Therapeutics Response to COVID-19 and Related Developments
7.8 Nuvox Pharma
7.8.1 Nuvox Pharma Business Overview
7.8.2 Nuvox Pharma Artificial Blood Quarterly Revenue, 2020
7.8.3 Nuvox Pharma Artificial Blood Product Introduction
7.8.4 Nuvox Pharma Response to COVID-19 and Related Developments
7.9 Alpha Therapeutic Corporation
7.9.1 Alpha Therapeutic Corporation Business Overview
7.9.2 Alpha Therapeutic Corporation Artificial Blood Quarterly Revenue, 2020
7.9.3 Alpha Therapeutic Corporation Artificial Blood Product Introduction
7.9.4 Alpha Therapeutic Corporation Response to COVID-19 and Related Developments
7.10 HemoBioTech
7.10.1 HemoBioTech Business Overview
7.10.2 HemoBioTech Artificial Blood Quarterly Revenue, 2020
7.10.3 HemoBioTech Artificial Blood Product Introduction
7.10.4 HemoBioTech Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Artificial Blood Industry
1.7 COVID-19 Impact: Artificial Blood Market Trends
2 GLOBAL ARTIFICIAL BLOOD QUARTERLY MARKET SIZE ANALYSIS
2.1 Artificial Blood Business Impact Assessment - COVID-19
2.1.1 Global Artificial Blood Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Artificial Blood Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Artificial Blood Quarterly Market Size, 2019 VS 2020
3.2 By Players, Artificial Blood Headquarters and Area Served
3.3 Date of Key Players Enter into Artificial Blood Market
3.4 Key Players Artificial Blood Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON ARTIFICIAL BLOOD SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Human Blood
1.4.2 Synthetic Blood
1.4.3 Animal Blood
4.2 By Type, Global Artificial Blood Market Size, 2019-2021
5 IMPACT OF COVID-19 ON ARTIFICIAL BLOOD SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hemoglobin-Based Oxygen Carriers (HBOCs)
5.5.2 Perflurocarbon Emulsions (PFCEs)
5.2 By Application, Global Artificial Blood Market Size, 2019-2021
5.2.1 By Application, Global Artificial Blood Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Dextro-Sang Corporation
7.1.1 Dextro-Sang Corporation Business Overview
7.1.2 Dextro-Sang Corporation Artificial Blood Quarterly Revenue, 2020
7.1.3 Dextro-Sang Corporation Artificial Blood Product Introduction
7.1.4 Dextro-Sang Corporation Response to COVID-19 and Related Developments
7.2 BioPure Corporation
7.2.1 BioPure Corporation Business Overview
7.2.2 BioPure Corporation Artificial Blood Quarterly Revenue, 2020
7.2.3 BioPure Corporation Artificial Blood Product Introduction
7.2.4 BioPure Corporation Response to COVID-19 and Related Developments
7.3 Sangart
7.3.1 Sangart Business Overview
7.3.2 Sangart Artificial Blood Quarterly Revenue, 2020
7.3.3 Sangart Artificial Blood Product Introduction
7.3.4 Sangart Response to COVID-19 and Related Developments
7.4 Northfield Laboratories
7.4.1 Northfield Laboratories Business Overview
7.4.2 Northfield Laboratories Artificial Blood Quarterly Revenue, 2020
7.4.3 Northfield Laboratories Artificial Blood Product Introduction
7.4.4 Northfield Laboratories Response to COVID-19 and Related Developments
7.5 Baxter International
7.5.1 Baxter International Business Overview
7.5.2 Baxter International Artificial Blood Quarterly Revenue, 2020
7.5.3 Baxter International Artificial Blood Product Introduction
7.5.4 Baxter International Response to COVID-19 and Related Developments
7.6 Dentritech
7.6.1 Dentritech Business Overview
7.6.2 Dentritech Artificial Blood Quarterly Revenue, 2020
7.6.3 Dentritech Artificial Blood Product Introduction
7.6.4 Dentritech Response to COVID-19 and Related Developments
7.7 FluorO2 Therapeutics
7.7.1 FluorO2 Therapeutics Business Overview
7.7.2 FluorO2 Therapeutics Artificial Blood Quarterly Revenue, 2020
7.7.3 FluorO2 Therapeutics Artificial Blood Product Introduction
7.7.4 FluorO2 Therapeutics Response to COVID-19 and Related Developments
7.8 Nuvox Pharma
7.8.1 Nuvox Pharma Business Overview
7.8.2 Nuvox Pharma Artificial Blood Quarterly Revenue, 2020
7.8.3 Nuvox Pharma Artificial Blood Product Introduction
7.8.4 Nuvox Pharma Response to COVID-19 and Related Developments
7.9 Alpha Therapeutic Corporation
7.9.1 Alpha Therapeutic Corporation Business Overview
7.9.2 Alpha Therapeutic Corporation Artificial Blood Quarterly Revenue, 2020
7.9.3 Alpha Therapeutic Corporation Artificial Blood Product Introduction
7.9.4 Alpha Therapeutic Corporation Response to COVID-19 and Related Developments
7.10 HemoBioTech
7.10.1 HemoBioTech Business Overview
7.10.2 HemoBioTech Artificial Blood Quarterly Revenue, 2020
7.10.3 HemoBioTech Artificial Blood Product Introduction
7.10.4 HemoBioTech Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Artificial Blood Assessment
Table 9. COVID-19 Impact: Artificial Blood Market Trends
Table 10. COVID-19 Impact Global Artificial Blood Market Size
Table 11. Global Artificial Blood Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Artificial Blood Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Artificial Blood Market Growth Drivers
Table 14. Global Artificial Blood Market Restraints
Table 15. Global Artificial Blood Market Opportunities
Table 16. Global Artificial Blood Market Challenges
Table 17. By Players, Artificial Blood Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Artificial Blood Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Artificial Blood Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Artificial Blood Market
Table 21. Key Players Artificial Blood Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Artificial Blood Market Size 2019-2021, (US$ Million)
Table 24. Global Artificial Blood Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Artificial Blood Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 57. Dextro-Sang Corporation Business Overview
Table 58. Dextro-Sang Corporation Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Dextro-Sang Corporation Artificial Blood Product
Table 60. Dextro-Sang Corporation Response to COVID-19 and Related Developments
Table 61. BioPure Corporation Business Overview
Table 62. BioPure Corporation Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. BioPure Corporation Artificial Blood Product
Table 64. BioPure Corporation Response to COVID-19 and Related Developments
Table 65. Sangart Business Overview
Table 66. Sangart Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Sangart Artificial Blood Product
Table 68. Sangart Response to COVID-19 and Related Developments
Table 69. Northfield Laboratories Business Overview
Table 70. Northfield Laboratories Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Northfield Laboratories Artificial Blood Product
Table 72. Northfield Laboratories Response to COVID-19 and Related Developments
Table 73. Baxter International Business Overview
Table 74. Baxter International Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Baxter International Artificial Blood Product
Table 76. Baxter International Response to COVID-19 and Related Developments
Table 77. Dentritech Business Overview
Table 78. Dentritech Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Dentritech Artificial Blood Product
Table 80. Dentritech Response to COVID-19 and Related Developments
Table 81. FluorO2 Therapeutics Business Overview
Table 82. FluorO2 Therapeutics Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. FluorO2 Therapeutics Artificial Blood Product
Table 84. FluorO2 Therapeutics Response to COVID-19 and Related Developments
Table 85. Nuvox Pharma Business Overview
Table 86. Nuvox Pharma Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Nuvox Pharma Artificial Blood Product
Table 88. Nuvox Pharma Response to COVID-19 and Related Developments
Table 89. Alpha Therapeutic Corporation Business Overview
Table 90. Alpha Therapeutic Corporation Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Alpha Therapeutic Corporation Artificial Blood Product
Table 92. Alpha Therapeutic Corporation Response to COVID-19 and Related Developments
Table 93. HemoBioTech Business Overview
Table 94. HemoBioTech Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. HemoBioTech Artificial Blood Product
Table 96. HemoBioTech Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Artificial Blood Assessment
Table 9. COVID-19 Impact: Artificial Blood Market Trends
Table 10. COVID-19 Impact Global Artificial Blood Market Size
Table 11. Global Artificial Blood Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Artificial Blood Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Artificial Blood Market Growth Drivers
Table 14. Global Artificial Blood Market Restraints
Table 15. Global Artificial Blood Market Opportunities
Table 16. Global Artificial Blood Market Challenges
Table 17. By Players, Artificial Blood Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Artificial Blood Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Artificial Blood Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Artificial Blood Market
Table 21. Key Players Artificial Blood Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Artificial Blood Market Size 2019-2021, (US$ Million)
Table 24. Global Artificial Blood Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Artificial Blood Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Artificial Blood Market Size, 2019-2021 (US$ Million)
Table 57. Dextro-Sang Corporation Business Overview
Table 58. Dextro-Sang Corporation Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Dextro-Sang Corporation Artificial Blood Product
Table 60. Dextro-Sang Corporation Response to COVID-19 and Related Developments
Table 61. BioPure Corporation Business Overview
Table 62. BioPure Corporation Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. BioPure Corporation Artificial Blood Product
Table 64. BioPure Corporation Response to COVID-19 and Related Developments
Table 65. Sangart Business Overview
Table 66. Sangart Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Sangart Artificial Blood Product
Table 68. Sangart Response to COVID-19 and Related Developments
Table 69. Northfield Laboratories Business Overview
Table 70. Northfield Laboratories Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Northfield Laboratories Artificial Blood Product
Table 72. Northfield Laboratories Response to COVID-19 and Related Developments
Table 73. Baxter International Business Overview
Table 74. Baxter International Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Baxter International Artificial Blood Product
Table 76. Baxter International Response to COVID-19 and Related Developments
Table 77. Dentritech Business Overview
Table 78. Dentritech Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Dentritech Artificial Blood Product
Table 80. Dentritech Response to COVID-19 and Related Developments
Table 81. FluorO2 Therapeutics Business Overview
Table 82. FluorO2 Therapeutics Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. FluorO2 Therapeutics Artificial Blood Product
Table 84. FluorO2 Therapeutics Response to COVID-19 and Related Developments
Table 85. Nuvox Pharma Business Overview
Table 86. Nuvox Pharma Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Nuvox Pharma Artificial Blood Product
Table 88. Nuvox Pharma Response to COVID-19 and Related Developments
Table 89. Alpha Therapeutic Corporation Business Overview
Table 90. Alpha Therapeutic Corporation Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Alpha Therapeutic Corporation Artificial Blood Product
Table 92. Alpha Therapeutic Corporation Response to COVID-19 and Related Developments
Table 93. HemoBioTech Business Overview
Table 94. HemoBioTech Artificial Blood Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. HemoBioTech Artificial Blood Product
Table 96. HemoBioTech Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Artificial Blood Product Picture
Figure 2. Artificial Blood Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Artificial Blood Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Artificial Blood Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Artificial Blood Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Artificial Blood Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Artificial Blood Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Artificial Blood Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Artificial Blood Market Size Market Share, 2019-2021
Figure 1. Artificial Blood Product Picture
Figure 2. Artificial Blood Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Artificial Blood Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Artificial Blood Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Artificial Blood Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Artificial Blood Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Artificial Blood Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Artificial Blood Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Artificial Blood Market Size Market Share, 2019-2021
